22208-3 |
Coccidioides immitis Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coccidioides immitis Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22208-3 |
|
|
|
|
Both |
|
|
|
0 |
C immitis Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; Dilution factor; Dilution Factor (Titer); G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Infectious Disease; InfectiousDisease; Microbiology; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; Random; San Joaquin Valley fever; Serum; SmQn; SR; T proteolyticum; Titer; Titered; Titre; Trichosporon proteolyticum; Ttr; Valley fever |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22209-1 |
Coccidioides immitis Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Coccidioides immitis IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22209-1 |
|
|
|
|
Both |
|
|
|
0 |
C immitis IgG Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Serum; SR; T proteolyticum; Trichosporon proteolyticum; Valley fever |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
2221-0 |
Elastase.pancreatic |
CCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Elastase.pancreatic [Enzymatic activity/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2221-0 |
|
|
|
|
Both |
|
|
|
0 |
Elastase Panc Ser-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; ELA; Elastase Panc; Pancr; Pancreatc; Pancreatic elastase 1; Pancreatic elastase I; Pancreatopeptidase E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
22210-9 |
Coccidioides immitis Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Coccidioides immitis IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22210-9 |
|
|
|
|
Both |
|
|
|
0 |
C immitis IgM Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Serum; SR; T proteolyticum; Trichosporon proteolyticum; Valley fever |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22211-7 |
Coxiella burnetii Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxiella burnetii Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22211-7 |
|
|
|
|
Both |
|
|
|
0 |
C burnet Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22212-5 |
Coxsackievirus A10 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A10 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22212-5 |
|
|
|
|
Both |
|
|
|
0 |
CV A10 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV A10; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22213-3 |
Coxsackievirus A10 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A10 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22213-3 |
|
|
|
|
Both |
|
|
|
0 |
CV A10 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A10; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22214-1 |
Coxsackievirus A16 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A16 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22214-1 |
|
|
|
|
Both |
|
|
|
0 |
CV A16 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV A16; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22215-8 |
Coxsackievirus A16 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A16 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22215-8 |
|
|
|
|
Both |
|
|
|
0 |
CV A16 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A16; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22216-6 |
Coxsackievirus A2 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A2 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22216-6 |
|
|
|
|
Both |
|
|
|
0 |
CV A2 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A2; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22217-4 |
Coxsackievirus A21 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A21 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22217-4 |
|
|
|
|
Both |
|
|
|
0 |
CV A21 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A21; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22218-2 |
Coxsackievirus A4 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A4 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22218-2 |
|
|
|
|
Both |
|
|
|
0 |
CV A4 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A4; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22219-0 |
Coxsackievirus A7 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A7 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22219-0 |
|
|
|
|
Both |
|
|
|
0 |
CV A7 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV A7; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
2222-8 |
Elastase.pancreatic 2 |
CCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Elastase.pancreatic 2 [Enzymatic activity/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2222-8 |
|
|
|
|
Both |
|
|
|
0 |
Elastase Panc2 Ser-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; ELA; Elastase Panc; Elastase Panc2; II; Pancr; Pancreatc; Pancreatic elastase 1; Pancreatic elastase I; Pancreatopeptidase E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
22220-8 |
Coxsackievirus A7 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A7 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22220-8 |
|
|
|
|
Both |
|
|
|
0 |
CV A7 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A7; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22221-6 |
Coxsackievirus A9 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A9 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22221-6 |
|
|
|
|
Both |
|
|
|
0 |
CV A9 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV A9; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22222-4 |
Coxsackievirus A9 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A9 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22222-4 |
|
|
|
|
Both |
|
|
|
0 |
CV A9 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A9; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22223-2 |
Coxsackievirus B Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Coxsackievirus B IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22223-2 |
|
|
|
|
Both |
|
|
|
0 |
CV B IgG Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CAV; CBV; Coxsackie; Coxsackie virus; CV; CV B; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22224-0 |
Coxsackievirus B Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Coxsackievirus B IgM Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22224-0 |
|
|
|
|
Both |
|
|
|
0 |
CV B IgM Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CAV; CBV; Coxsackie; Coxsackie virus; CV; CV B; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22225-7 |
Coxsackievirus B1 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B1 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22225-7 |
|
|
|
|
Both |
|
|
|
0 |
CV B1 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV B1; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22226-5 |
Coxsackievirus B1 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B1 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22226-5 |
|
|
|
|
Both |
|
|
|
0 |
CV B1 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV B1; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22227-3 |
Coxsackievirus B2 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B2 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22227-3 |
|
|
|
|
Both |
|
|
|
0 |
CV B2 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV B2; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22228-1 |
Coxsackievirus B2 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B2 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22228-1 |
|
|
|
|
Both |
|
|
|
0 |
CV B2 Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV B2; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22229-9 |
Coxsackievirus B3 Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus B3 Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22229-9 |
|
|
|
|
Both |
|
|
|
0 |
CV B3 Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV B3; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
2223-6 |
Elastase.leukocyte |
CCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Elastase.leukocyte [Enzymatic activity/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2223-6 |
|
|
|
|
Both |
|
|
|
0 |
Elastase Leukocyte Plas-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; ELA; Elastase Leukocyte; Leuc; Leuk; Leukocyte elastase; Leukocytes; Lkcs; Lysosomal elastase; Neutrophil elastase; Pl; Plasma; Plsm; PMN Elastase; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.68 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
Component was corrected from "leukocytary" to "leukocyte" |
0 |